Japan useful medication program for schizophrenia (JUMPs)-long-term study on discontinuation rate, resolution and remission, and improvement in social functioning rate associated with atypical antipsychotic medications in patients with schizophrenia
- Publication date
- 25 June 2020
- Publisher
- BioMed Central|Springer Nature